S100A7A 抗体 (AA 41-108)
Quick Overview for S100A7A 抗体 (AA 41-108) (ABIN718301)
抗原
See all S100A7A 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 41-108
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from mouse S100A15
-
亚型
- IgG
-
-
-
-
应用备注
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
-
Visfatin enhances the production of cathelicidin antimicrobial peptide, human ?-defensin-2, human ?-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced ..." in: The American journal of pathology, Vol. 182, Issue 5, pp. 1705-17, (2013) (PubMed).
: "
-
Visfatin enhances the production of cathelicidin antimicrobial peptide, human ?-defensin-2, human ?-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced ..." in: The American journal of pathology, Vol. 182, Issue 5, pp. 1705-17, (2013) (PubMed).
-
- S100A7A (S100 Calcium Binding Protein A7A (S100A7A))
-
别名
- S100A15
-
背景
-
Synonyms: Gm12, S1A7f, S1a15, AY46519, S1A7L1, S1a15a, S1a17l1, Protein S1-A15A, Protein S1-A7A, S1 calcium-binding protein A15A, S1 calcium-binding protein A7A, S1a7, S1a7a
Background: Fetal ear, skin, and tongue and human cell lines. Highly up-regulated in psoriatic epidermis. Also highly expressed in the urine of bladder squamous cell carcinoma (SCC) bearing patients.
-
基因ID
- 381493
-
UniProt
- Q6S5I3
-
途径
- Activation of Innate immune Response, S100 Proteins
抗原
-